These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 30655087)

  • 1. The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
    Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of radiation and immunotherapy in the treatment of genitourinary malignancies: A systematic review and meta-analysis.
    Maisch P; Koll F; Bolenz C; Chun FK; Gschwend JE; Schmid SC
    Urol Oncol; 2023 May; 41(5):219-232. PubMed ID: 36372634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiome and Prostate Cancer Risk.
    Wheeler KM; Liss MA
    Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary microbiome profile in men with genitourinary malignancies.
    Ahn HK; Kim K; Park J; Kim KH
    Investig Clin Urol; 2022 Sep; 63(5):569-576. PubMed ID: 36068003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bibliography. Current world literature. Genitourinary systems.
    Curr Opin Oncol; 2000 May; 12(3):B104-33. PubMed ID: 10841204
    [No Abstract]   [Full Text] [Related]  

  • 6. The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.
    Kustrimovic N; Bilato G; Mortara L; Baci D
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38339010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.
    Shrestha E; White JR; Yu SH; Kulac I; Ertunc O; De Marzo AM; Yegnasubramanian S; Mangold LA; Partin AW; Sfanos KS
    J Urol; 2018 Jan; 199(1):161-171. PubMed ID: 28797714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis.
    Stamatakos PV; Fragkoulis C; Zoidakis I; Ntoumas K; Kratiras Z; Mitsogiannis I; Dellis A
    World J Urol; 2024 Jul; 42(1):457. PubMed ID: 39073494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Imaging to Predict Treatment Response in Genitourinary Malignancies.
    Lebastchi AH; Watson MJ; Russell CM; George AK; Weizer AZ; Turkbey B
    Eur Urol Focus; 2018 Dec; 4(6):804-817. PubMed ID: 28918178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urobiome in Gender-Related Diversities of Bladder Cancer.
    Bilski K; Dobruch J; Kozikowski M; Skrzypczyk MA; Oszczudłowski M; Ostrowski J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiome of the urinary tract--a role beyond infection.
    Whiteside SA; Razvi H; Dave S; Reid G; Burton JP
    Nat Rev Urol; 2015 Feb; 12(2):81-90. PubMed ID: 25600098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Tumor and Host Microbiome on Immunotherapy Response in Urologic Cancers.
    Pfail J; Drobner J; Doppalapudi K; Saraiya B; Packiam V; Ghodoussipour S
    J Cancer Immunol (Wilmington); 2024; 6(1):1-13. PubMed ID: 38846356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota and prostate cancer.
    Rizzo A; Santoni M; Mollica V; Fiorentino M; Brandi G; Massari F
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1058-1065. PubMed ID: 34536504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
    Surolia I; Gulley J; Madan RA
    Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma.
    Yang JW; Wan S; Li KP; Chen SY; Yang L
    Front Immunol; 2023; 14():1188520. PubMed ID: 37441065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
    Sanford EJ; Drago JR; Rohner TJ; Kessler GF; Sheehan L; Lipton A
    J Urol; 1975 Feb; 113(2):218-21. PubMed ID: 1113419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genitourinary malignancy.
    Hudes GR; Ozols RF; Giantonio B
    Cancer Chemother Biol Response Modif; 1994; 15():531-54. PubMed ID: 7779598
    [No Abstract]   [Full Text] [Related]  

  • 19. Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A Review.
    Russo AE; Memon A; Ahmed S
    Clin Genitourin Cancer; 2024 Apr; 22(2):434-444. PubMed ID: 38220540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Bajic P; Wolfe AJ; Gupta GN
    Urology; 2019 Apr; 126():10-15. PubMed ID: 30615894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.